Name | Number of supported studies | Average coverage | |
---|---|---|---|
pro-B cell | 4 studies | 51% ± 21% | |
precursor B cell | 3 studies | 37% ± 13% |
Insufficient scRNA-seq data for expression of RAG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 162.00 | 89 / 89 | 68% | 1.65 | 614 / 901 |
esophagus | 92% | 42.79 | 1323 / 1445 | 61% | 2.16 | 112 / 183 |
lung | 94% | 75.72 | 545 / 578 | 45% | 1.33 | 524 / 1155 |
stomach | 98% | 66.16 | 352 / 359 | 35% | 0.69 | 100 / 286 |
bladder | 100% | 53.24 | 21 / 21 | 33% | 0.80 | 165 / 504 |
intestine | 98% | 80.96 | 950 / 966 | 34% | 0.65 | 181 / 527 |
thymus | 100% | 244.63 | 651 / 653 | 32% | 37.00 | 196 / 605 |
pancreas | 98% | 63.98 | 323 / 328 | 25% | 0.48 | 44 / 178 |
adrenal gland | 98% | 191.30 | 253 / 258 | 19% | 0.31 | 44 / 230 |
uterus | 96% | 56.41 | 164 / 170 | 21% | 0.48 | 95 / 459 |
skin | 87% | 44.19 | 1569 / 1809 | 28% | 0.50 | 130 / 472 |
breast | 97% | 80.47 | 445 / 459 | 14% | 0.24 | 161 / 1118 |
ovary | 93% | 56.82 | 167 / 180 | 16% | 0.28 | 70 / 430 |
liver | 96% | 67.85 | 218 / 226 | 7% | 0.17 | 29 / 406 |
spleen | 100% | 380.50 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 94% | 60.05 | 231 / 245 | 4% | 0.09 | 20 / 502 |
adipose | 97% | 74.52 | 1165 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 54.78 | 825 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 88% | 44.52 | 1180 / 1335 | 0% | 0 | 0 / 0 |
brain | 76% | 22.92 | 2011 / 2642 | 3% | 0.04 | 21 / 705 |
muscle | 59% | 16.31 | 475 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 0.71 | 14 / 45 |
peripheral blood | 25% | 48.32 | 231 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 18% | 0.23 | 14 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0043029 | Biological process | T cell homeostasis |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0033151 | Biological process | V(D)J recombination |
GO_0008542 | Biological process | visual learning |
GO_2000822 | Biological process | regulation of behavioral fear response |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0048538 | Biological process | thymus development |
GO_0070244 | Biological process | negative regulation of thymocyte apoptotic process |
GO_0006310 | Biological process | DNA recombination |
GO_0002331 | Biological process | pre-B cell allelic exclusion |
GO_0030183 | Biological process | B cell differentiation |
GO_0005654 | Cellular component | nucleoplasm |
GO_1905347 | Cellular component | endodeoxyribonuclease complex |
GO_0097519 | Cellular component | DNA recombinase complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0042393 | Molecular function | histone binding |
GO_1990238 | Molecular function | double-stranded DNA endonuclease activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RAG1 |
Protein name | V(D)J recombination-activating protein 1 (EC 2.3.2.27) (EC 3.1.-.-) V(D)J recombination-activating protein 1 (RAG-1) (RING finger protein 74) [Includes: Endonuclease RAG1 (EC 3.1.-.-); E3 ubiquitin-protein ligase RAG1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RAG1)] |
Synonyms | RNF74 |
Description | FUNCTION: Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In addition to its endonuclease activity, RAG1 also acts as an E3 ubiquitin-protein ligase that mediates monoubiquitination of histone H3. Histone H3 monoubiquitination is required for the joining step of V(D)J recombination. Mediates polyubiquitination of KPNA1 (By similarity). . FUNCTION: Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. . FUNCTION: Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. . FUNCTION: Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. . |
Accessions | ENST00000534663.1 [P15918-2] A0A6F7R8J6 Q9BYY2 P15918 ENST00000299440.6 [P15918-1] A0A6F7R719 ENST00000697713.1 [P15918-1] ENST00000697715.1 [P15918-1] ENST00000697714.1 [P15918-1] |